Related Experiment Videos
Betamethasone valerate ointment compared with fluocinonide FAPG
Archives of Dermatology
|May 1, 1977
Summary
Betamethasone valerate ointment is more effective than fluocinonide FAPG for eczema and psoriasis. The ointment base significantly enhances betamethasone valerate
Area of Science:
- Dermatology
- Pharmacology
Background:
- Eczema and psoriasis are common inflammatory skin conditions.
- Topical corticosteroids are a mainstay treatment for these conditions.
Purpose of the Study:
- To compare the efficacy of betamethasone valerate ointment with fluocinonide FAPG.
- To evaluate the role of the base in corticosteroid efficacy.
Main Methods:
- A double-blind clinical trial involving 76 patients.
- Patients had either eczema or psoriasis.
- Comparison of betamethasone 0.1% ointment vs. fluocinonide 0.05% FAPG.
Main Results:
- Betamethasone valerate ointment showed statistically significant superiority (P < .05) over fluocinonide FAPG.
- This superiority was observed in treating both eczema and psoriasis.
- Findings suggest the ointment base enhances betamethasone valerate's effectiveness.
Conclusions:
- Betamethasone valerate in an ointment base is a highly effective treatment for eczema and psoriasis.
- The formulation's base plays a crucial role in enhancing corticosteroid efficacy.
- Further research into base-vehicle interactions for topical corticosteroids is warranted.